Men are, on the whole, terrible at going to the doctors. And that was before the onset of Covid-19 made the idea of a trip to the local GP akin to running an assault cause.
Indeed, recent findings show that three out of four men don't go to the doctor when something is wrong.
When you consider that men are also more likely to get cancer, heart disease and become overweight, as well as being more prone to smoking, drinking, and abusing drugs, well, this isn’t exactly good news, chaps.
What is good news is that digital health startup Numan has the answer – and has just managed to complete a £10m Series A funding round, led by Novator, along with Anthemis Exponential, Vostok New Ventures, and Colle Capital.
Launched in February 2019, Numan helps men take action when it comes to their health and wellbeing. The company provides regulated treatment options for the most common male health concerns, with a team of clinicians who can create personalised treatment plans online.
We are building a new kind of healthcare company that gives men simple and accessible solutions for their health and wellbeing problems
“We are building a new kind of healthcare company that gives men simple and accessible solutions for their health and wellbeing problems,” said Sokratis Papafloratos, Numan’s Founder and CEO.
“We help men understand their health better through a series of diagnostics and clinician consultations, and offer medical solutions that cover anything from Sexual Health, to Hair Loss, Smoking Cessation and General Wellbeing - all via a comprehensive digital health platform.
"The Covid crisis is motivating men to take better care of themselves and we look forward to becoming a holistic health partner for them, backed by a world-class team of investors.”
Numan intends to use the funds it’s raised to continue investing in technology, expand operations, and grow the team, with Sam Shah, ex Director of Digital Development for NHSX recently joining as Chief Medical Strategy Officer.
For more information, visit numan.com
